Sherbrooke Park Advisers LLC Enanta Pharmaceuticals Inc Transaction History
Sherbrooke Park Advisers LLC
- $230 Billion
- Q2 2025
A detailed history of Sherbrooke Park Advisers LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 12,538 shares of ENTA stock, worth $136,162. This represents 0.04% of its overall portfolio holdings.
Number of Shares
12,538
Previous 20,975
40.22%
Holding current value
$136,162
Previous $116 Million
18.13%
% of portfolio
0.04%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding ENTA
# of Institutions
108Shares Held
18.7MCall Options Held
50KPut Options Held
0-
Farallon Capital Management LLC San Francisco, CA2.12MShares$23 Million0.07% of portfolio
-
Krensavage Asset Management, LLC New York, NY2.11MShares$23 Million8.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$21.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$20.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.46MShares$15.8 Million0.01% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $225M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...